Nitroderm TTS is a transdermal therapeutic system primarily used for treating angina pectoris, a condition characterized by chest pain or discomfort caused by reduced blood flow to the heart. It is a medication that contains the active ingredient nitroglycerin, which belongs to the class of drugs known as nitrates.
Nitroderm TTS is an adhesive patch designed to be applied on the skin, allowing the medication to be absorbed directly into the bloodstream. The patch releases a controlled amount of nitroglycerin over a specific period, typically 24 hours, ensuring a continuous supply of the drug.
Once absorbed, nitroglycerin converts into nitric oxide, a vasodilator that relaxes and widens the blood vessels. By dilating the coronary arteries, nitroderm TTS helps to increase blood flow to the heart, relieving chest pain and reducing the workload on the heart muscle. It also helps to widen peripheral blood vessels, resulting in improved blood flow throughout the body.
Nitroderm TTS is available in different strengths, with the appropriate dosage determined by the prescribing healthcare professional. It is essential to follow the instructions for use, including the recommended patch placement locations, to ensure optimal absorption and effectiveness.
While most people can use Nitroderm TTS safely, it is important to inform the healthcare provider about any pre-existing medical conditions, current medications, or allergies. Side effects may occur, such as headache, dizziness, flushing, or skin irritations. Any persistent or severe side effects should be reported to a healthcare professional.
In summary, Nitroderm TTS is a transdermal patch containing nitroglycerin, used to treat angina pectoris by dilating blood vessels and increasing blood flow to
